Battle for muscular dystrophy drugs

Over the next couple of weeks two drugs that combat a rare and fatal form of muscular dystrophy will come under review, in what could be a watershed moment for patients.

This entry was posted in Biotech & Pharmaceuticals, Drugs, NBR Show Clips. Bookmark the permalink.

Leave a Reply